New research suggests that psilocybin, a compound found in magic mushrooms, may be effective in treating depression symptoms.
An Australian biopharma company said Thursday that it has received approval to begin a series of clinical trials for its LSD microdosing drug designed as an aid to women’s health.
An RCT suggests transcranial alternating current stimulation may be an effective treatment for major depression, but outside ...
Psilocybin outperformed a variety of "control" treatments in easing symptoms of depression, researchers reported Wednesday in ...
The active chemical in magic mushrooms could prove to be a powerful antidepressant, a new review finds.Psilocybin outp ...
Psilocybin - the active ingredient in "magic" mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, ...
Traditional treatments for depression often include medications and therapy ... psilocybin does not seem to have addictive properties and typically has few side effects. The recent study conducted by ...
A recent observational study conducted by a team of UK-based researchers found that medical cannabis may be beneficial for ...
Researchers say a plant-based diet can help ease the side effects for men being treated for prostate cancer, especially those ...
Psilocybin - the active ingredient in “magic” mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, ...
NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.
Psychedelic-assisted therapy is poised to move from the research setting to clinical practice, and a group of experts offer seven essential elements of informed consent for psychedelic therapy.